ICYMI: Grassley Pushes His Prescription Drug Plan
Senator Cites Bipartisan Support, Saying Americans ‘Want This’ Cedar Rapids Gazette By James Lynch Americans want lower prescription drug prices. Sen. Chuck Grassley has a plan for that. The Iowa Republican who chairs the Senate Finance Committee said Wednesday that support is growing in the Senate for his Prescription Drug Pricing Reduction […]
Grassley, Rubio Seek Answers on HHS Funded Genetic Testing Connected to China, Russia
WASHINGTON – Senate Finance Committee Chairman Chuck Grassley (R-Iowa) and Sen. Marco Rubio (R-Fla.) wrote to Department of Health and Human Services (HHS) Secretary Alex Azar and Centers for Medicare and Medicaid Services (CMS) Administrator Seema Verma seeking an update on the status of a congressionally-mandated report which requires CMS to detail the circumstances in […]
Grassley: Ending Big Pharma’s Pricing Tricks Would be a Real Treat
Prepared Floor Remarks by U.S. Senator Chuck Grassley of Iowa Chairman, Senate Finance Committee Thursday, October 31, 2019 VIDEO Today is Halloween. This may sound a little candy corn-y, but this Iowan wants to talk about the scary prices of prescription drugs. Since January, I’ve joined bipartisan forces to drive a stake […]
Why It’s Smart for Republicans to Act on Prescription Drug Prices
Why It’s Smart for Republicans to Act on Prescription Drug Prices By John Blanton RealClearPolitics.com Going into the 2020 election, President Trump and Senate Republicans must take serious action regarding one of the most highly polled and oft-cited issues of concern: health care. Not only will the issue be key to retaining the White […]
Grassley, Braun op-ed: How the Prescription Drug Pricing Reduction Act can reduce drug costs
How the Prescription Drug Pricing Reduction Act can reduce drug costs By Sens. Chuck Grassley and Mike Braun The cost of prescription drugs is too high, plain and simple. It’s a chorus we hear repeatedly from our constituents in Indiana and Iowa. If you ask any of our colleagues in the Senate and House of Representatives, […]
Grassley op-ed: America will suffer if problems plaguing Midwest aren’t addressed by Congress
America will suffer if problems plaguing Midwest aren’t addressed by Congress By Senate Finance Committee Chairman Chuck Grassley Members of Congress representing Middle America have been talking about the challenges facing the Midwest for years, but our warnings have largely fallen on deaf ears. Why? Because too often, Congress doesn’t act on a problem until […]
Grassley at Hearing on One-Year Anniversary of Landmark Anti-Opioid Legislation
Prepared Opening Statement by U.S. Senator Chuck Grassley of Iowa Chairman, Senate Finance Committee Hearing on Treating Substance Misuse in America Thursday, October 24, 2019 Good morning. I want to welcome our panelists to today’s hearing on the one-year anniversary of the SUPPORT Act. This landmark statute, which many of us had a hand in […]
Grassley on Repealing the SALT Tax
Grassley on Repealing the SALT Tax Prepared Floor Remarks by U.S. Senator Chuck Grassley of Iowa Chairman, Senate Finance Committee Wednesday, October 23, 2019 VIDEO This week Democrats are using the Congressional Review Act to force a vote on a resolution that would effectively repeal an IRS regulation aimed at preventing millionaires and […]
Grassley: Congress Must Act Soon on USMCA
Grassley: Congress Must Act Soon on USMCA Prepared Floor Remarks by U.S. Senator Chuck Grassley of Iowa Chairman, Senate Finance Committee Wednesday, October 23, 2019 VIDEO I come to the Senate floor today to express a growing worry: the Democratically-controlled House of Representatives looks increasingly less likely to act this year on USMCA. That […]
Grassley, Cassidy Op-ed: A Bipartisan Way To Make Prescription Drugs Affordable
A Bipartisan Way To Make Prescription Drugs Affordable By Sens. Chuck Grassley and Bill Cassidy Americans are concerned about the high price of drugs. The pharmaceutical industry has become a system rife with gaming. Profits are regularly prioritized over patients. Laws meant to encourage innovation, recoup private investment, and ensure patient access are too […]